InvestLog
DNTH Dianthus Therapeutics, Inc. logo

DNTH Dianthus Therapeutics, Inc.

Healthcare
$86.82+0.39%ClosedMarket Cap: $3.62B

As of 2026-05-26

Insider Statistics (Q2 2026)

Acquisitions

9

Dispositions

4

Buy/Sell Ratio

2.25

Net Shares

+33,807

Shares Acquired

51,453

Shares Disposed

17,646

Total Bought ($)

$0.00

Total Sold ($)

$2.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri May 22Violin JonathandirectorSell6,090$89.636,090
Fri May 22Soteropoulos PauladirectorSell6,090$89.636,090
Fri May 22Romano Steven J.directorSell6,090$89.636,090
Fri May 22Read SimondirectorSell6,090$89.636,090
Fri May 22McGeorge AnnedirectorSell6,090$89.636,090
Fri May 22Lawton Alison FrancesdirectorSell6,090$89.636,090
Fri May 22KANGO SUJAYdirectorSell6,090$89.636,090
Mon May 11Soteropoulos PauladirectorSell599$85.470
Mon May 11Soteropoulos PauladirectorSell599$8.44599
Fri Apr 10Savitz Ryanofficer: EVP, CFO & CBOSell8,224$89.840
Fri Apr 10Savitz Ryanofficer: EVP, CFO & CBOSell8,224$17.8871,776
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell59,800$83.9026,701
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell21,825$78.8691,152
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell2,366$82.8486,501
Wed Apr 01Savitz Ryanofficer: EVP, CFO & CBOSell1,485$80.2589,667